- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT02393651
Late LTP-like Plasticity Effects of tDCS in Subacute Stroke Patients
Rationale: About 80% of stroke patients suffer motor impairments, but current therapies have limited effects on motor recovery. Therefore, investigating new potential therapeutic approaches is crucial. Transcranial Direct Current Stimulation (tDCS) is a form of non-invasive electrical stimulation where a weak current is applied through electrodes over the scalp. This stimulation is known to (1) induce changes in neuronal excitability -which can last up to one day with late LTP-like plasticity protocols in a polarity and site-specific manner, and (2) facilitate motor learning and stroke recovery. So far, several pilot studies have reported beneficial results from tDCS in both subacute and chronic stroke patients, but it's still unclear how tDCS should be repeated over multiple days to optimally enhance recovery and training effects. Using a late LTP-like plasticity protocol could increase effectiveness of standard clinical care rehabilitation sessions and thus enhance the effects of rehabilitation. Therefore, the investigators want to investigate how late LTP-like plasticity tDCS affects rehabilitation in subacute stroke patients. The outcome of this study can provide important guidelines on effective motor therapy during stroke rehabilitation.
Objective: Identify the effect of late LTP-like plasticity on motor rehabilitation during the subacute phase after stroke.
Study design: Double-blinded, randomized between-subjects trials. Study population: Subacute stroke patients. Main study parameters/endpoints: The primary outcome measure is the upper limb motor function during the subacute phase after stroke.
Studie Overzicht
Studietype
Inschrijving (Verwacht)
Fase
- Niet toepasbaar
Contacten en locaties
Studie Locaties
-
-
Zuid-Holland
-
Rotterdam, Zuid-Holland, Nederland, 3015LJ
- Werving
- Rijndam
-
Contact:
- Gerard Ribbers, PhD MD
- Telefoonnummer: +31102412411
- E-mail: gribbers@rijndam.nl
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Beschrijving
Inclusion Criteria:
- Subacute stroke (within 1-4 weeks post stroke)
- Acute hemiparesis (Fugl-Meyer Stage < IV) with single thromboembolic non-hemorrhagic infarction documented by a neurologist
- Aged 18-79
Exclusion Criteria:
- Absence of voluntary movement (Fugl-Meyer Stage < III)
- Head injury or the presence of intracranial metal or intracranial lesions
- History of cranial irradiation
- History of epilepsy
- Presence of a pacemaker
- Taking anticonvulsant or neuroleptic medication
- Substance abuse
- Inability to understand instructions
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Behandeling
- Toewijzing: Gerandomiseerd
- Interventioneel model: Parallelle opdracht
- Masker: Verviervoudigen
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
|---|---|
|
Placebo-vergelijker: Sham
Motor training of the affected upper extremity combined with sham tDCS.
|
Late LTP-like plasticity tDCS (2 times per week) for 4 weeks.
|
|
Experimenteel: tDCS
Motor training of the affected upper extremity combined with dual transcranial direct current stimulation (tDCS).
|
Late LTP-like plasticity tDCS (2 times per week) for 4 weeks.
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Tijdsspanne |
|---|---|
|
Change from baseline in Upper Extremity Fugl Meyer Assessment
Tijdsspanne: Baseline, 1 week, 2 weeks, 4 weeks and 12 weeks
|
Baseline, 1 week, 2 weeks, 4 weeks and 12 weeks
|
Secundaire uitkomstmaten
Uitkomstmaat |
Tijdsspanne |
|---|---|
|
ARAT
Tijdsspanne: Baseline, 1 week, 2 weeks, 4 weeks and 12 weeks
|
Baseline, 1 week, 2 weeks, 4 weeks and 12 weeks
|
|
Hand grip strength
Tijdsspanne: Baseline, 1 week, 2 weeks, 4 weeks and 12 weeks
|
Baseline, 1 week, 2 weeks, 4 weeks and 12 weeks
|
|
10-meter walk test
Tijdsspanne: Baseline; 1 week, 2 weeks, 4 weeks and 12 weeks
|
Baseline; 1 week, 2 weeks, 4 weeks and 12 weeks
|
|
EuroQol-5D
Tijdsspanne: 12 weeks
|
12 weeks
|
|
Barthel Index
Tijdsspanne: Baseline; 1 week, 2 weeks, 4 weeks and 12 weeks
|
Baseline; 1 week, 2 weeks, 4 weeks and 12 weeks
|
|
HADS
Tijdsspanne: Baseline; 4 weeks and 12 weeks
|
Baseline; 4 weeks and 12 weeks
|
|
MoCA
Tijdsspanne: Baseline; 4 weeks and 12 weeks
|
Baseline; 4 weeks and 12 weeks
|
|
Wong-Baker FACES Pain Rating Scale
Tijdsspanne: Every stimulation session
|
Every stimulation session
|
Medewerkers en onderzoekers
Sponsor
Publicaties en nuttige links
Studie record data
Bestudeer belangrijke data
Studie start
Primaire voltooiing (Verwacht)
Studie voltooiing (Verwacht)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Schatting)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- MEC-2014-503
- NL49887.078.14 (Andere identificatie: CCMO)
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .